EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East and Africa, and Porton Advanced Solutions, a global leading cell and gene ...

Porton Advanced Solutions and EVA Pharma have signed a memorandum of understanding (MoU) to enhance the development and manufacturing capabilities for chimeric antigen receptor (CAR) T-cell ...

Porton Advanced Solutions and EVA Pharma have signed a memorandum of understanding (MoU) to enhance the development and manufacturing capabilities for chimeric antigen receptor (CAR) T-cell therapies ...

The new branch will focus on research and development and strategic supply operations in the field of pharmaceuticals, vaccines, and biologics. “By anchoring our presence in leading innovation hubs ...

Porton Advanced Solutions, a global leading cell and gene therapy CDMO service provider, and EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across ...

EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 70 countries worldwide.

A new era of personalized gene therapy for Leukemia patients in Egypt, Saudi Arabia, and beyond. SUZHOU, China and CAIRO, June 26, 2025 /PRNewswire/ — Porton Advanced Solutions, a global leading cell ...